Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C13H17N |
| Molecular Weight | 187.2808 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CC1=CC=CC=C1)N(C)CC#C
InChI
InChIKey=MEZLKOACVSPNER-UHFFFAOYSA-N
InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3
| Molecular Formula | C13H17N |
| Molecular Weight | 187.2808 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons. | 1991 Nov |
|
| Pharmacokinetic aspects of l-deprenyl (selegiline) and its metabolites. | 1994 Dec |
|
| Monoamine oxidase B inhibitors for early Parkinson's disease. | 2005 Jul 20 |
|
| Transdermal selegiline for the treatment of major depressive disorder. | 2007 |
|
| A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression. | 2008 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:43:35 GMT 2023
by
admin
on
Sat Dec 16 05:43:35 GMT 2023
|
| Record UNII |
DPF682Q08V
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID60860142
Created by
admin on Sat Dec 16 05:43:35 GMT 2023 , Edited by admin on Sat Dec 16 05:43:35 GMT 2023
|
PRIMARY | |||
|
SUB10474MIG
Created by
admin on Sat Dec 16 05:43:35 GMT 2023 , Edited by admin on Sat Dec 16 05:43:35 GMT 2023
|
PRIMARY | |||
|
m9835
Created by
admin on Sat Dec 16 05:43:35 GMT 2023 , Edited by admin on Sat Dec 16 05:43:35 GMT 2023
|
PRIMARY | Merck Index | ||
|
DPF682Q08V
Created by
admin on Sat Dec 16 05:43:35 GMT 2023 , Edited by admin on Sat Dec 16 05:43:35 GMT 2023
|
PRIMARY | |||
|
5195
Created by
admin on Sat Dec 16 05:43:35 GMT 2023 , Edited by admin on Sat Dec 16 05:43:35 GMT 2023
|
PRIMARY | |||
|
2323-36-6
Created by
admin on Sat Dec 16 05:43:35 GMT 2023 , Edited by admin on Sat Dec 16 05:43:35 GMT 2023
|
PRIMARY | |||
|
Deprenyl
Created by
admin on Sat Dec 16 05:43:35 GMT 2023 , Edited by admin on Sat Dec 16 05:43:35 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> INHIBITOR |
IRREVERSIBLE INHIBITOR
|
||
|
TARGET -> INHIBITOR |
Enzymatic Assay
IC50
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
